Definium Therapeutics, Inc. (DFTX)
38.33
-0.35
(-0.90%)
USD |
NASDAQ |
Sep 18, 12:02
Definium Therapeutics Price to Book Value : 5.606 for Sept. 18, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 17, 2026 | 5.657 |
| September 16, 2026 | 5.536 |
| September 15, 2026 | 5.385 |
| September 14, 2026 | 5.887 |
| September 11, 2026 | 5.688 |
| September 10, 2026 | 5.518 |
| September 09, 2026 | 5.556 |
| September 08, 2026 | 5.592 |
| September 04, 2026 | 5.571 |
| September 03, 2026 | 5.558 |
| September 02, 2026 | 5.690 |
| September 01, 2026 | 5.631 |
| August 31, 2026 | 5.809 |
| August 28, 2026 | 5.994 |
| August 27, 2026 | 6.409 |
| August 26, 2026 | 6.402 |
| August 25, 2026 | 6.554 |
| August 24, 2026 | 6.329 |
| August 21, 2026 | 6.568 |
| August 20, 2026 | 6.640 |
| August 19, 2026 | 6.702 |
| August 18, 2026 | 6.754 |
| August 17, 2026 | 6.620 |
| August 14, 2026 | 6.235 |
| August 13, 2026 | 6.421 |
| Date | Value |
|---|---|
| August 12, 2026 | 6.258 |
| August 11, 2026 | 5.984 |
| August 10, 2026 | 6.604 |
| August 07, 2026 | 6.748 |
| August 06, 2026 | 6.748 |
| August 05, 2026 | 6.492 |
| August 04, 2026 | 6.190 |
| August 03, 2026 | 6.112 |
| July 31, 2026 | 6.365 |
| July 30, 2026 | 6.507 |
| July 29, 2026 | 6.166 |
| July 28, 2026 | 6.137 |
| July 27, 2026 | 6.238 |
| July 24, 2026 | 6.314 |
| July 23, 2026 | 6.279 |
| July 22, 2026 | 6.387 |
| July 21, 2026 | 6.593 |
| July 20, 2026 | 6.260 |
| July 17, 2026 | 6.478 |
| July 16, 2026 | 6.450 |
| July 15, 2026 | 6.678 |
| July 14, 2026 | 6.725 |
| July 13, 2026 | 6.384 |
| July 10, 2026 | 6.884 |
| July 09, 2026 | 7.086 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Cocrystal Pharma, Inc. | 15.45 |
| CNBX Pharmaceuticals, Inc. | -- |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | 0.9606 |
| Fulcrum Therapeutics, Inc. | 0.9268 |
Price to Book Value Related Metrics
| PEG Ratio | -0.0826 |
| Price | 38.33 |
| Earnings Yield | -8.97% |
| Market Cap | 5.150B |
| PEGY Ratio | -0.0826 |